Log In
Print
BCIQ
Print
Print this Print this
 

icaritin (SNG-162)

  Manage Alerts
Collapse Summary General Information
Company Shenogen Pharma Group Ltd.
DescriptionSmall molecule derived from a Chinese herb targeting estrogen receptor alpha 36
Molecular Target Estrogen receptor alpha 36
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today